• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同乳腺影像报告和数据系统分类的乳腺癌患者临床病理特征及预后比较

Comparison of clinicopathological characteristics and prognosis in breast cancer patients with different Breast Imaging Reporting and Data System categories.

作者信息

Kim Bong Kyun, Ryu Jai Min, Oh Se Jeong, Han Jaihong, Choi Jung Eun, Jeong Joon, Suh Young Jin, Lee Jina, Sun Woo Young

机构信息

Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea.

Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Ann Surg Treat Res. 2021 Sep;101(3):131-139. doi: 10.4174/astr.2021.101.3.131. Epub 2021 Aug 31.

DOI:10.4174/astr.2021.101.3.131
PMID:34549036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8424435/
Abstract

PURPOSE

The Breast Imaging Reporting and Data System (BI-RADS) is a systematic and standardized scheme of the radiological findings of breast. However, there were different BI-RADS categories between breast cancers as the clinical characteristics in previous studies. We analyzed the association of BI-RADS categories with the clinicopathological characteristics and prognosis of breast cancer.

METHODS

A total of 44,184 patients with invasive breast cancers assigned to BI-RADS category 3, 4, or 5 in preoperative mammography or ultrasonography were analyzed retrospectively using large-scale data from the Korean Breast Cancer Society registration system. The difference in the clinicopathological factors and prognoses according to the BI-RADS categories (BI-RADS 3-4 and BI-RADS 5) were compared between the mammography and ultrasonography groups. Comparisons of the clinicopathological factors in both groups were made using logistic regression analysis, while the prognoses were based on the breast cancer-specific survival using the Kaplan-Meier method and Cox proportional hazards model.

RESULTS

The factors associated with BI-RADS were T stage, N stage, palpability, histology grade, and lymphovascular invasion in the mammography group; and N stage, palpability, histology grade, and lymphovascular invasion in the ultrasonography group. In the survival analysis, there were significant differences in the breast cancer-specific survival of the BI-RADS category groups in both of the mammography (hazard ratio [HR], 3.366; P < 0.001) and ultrasonography (HR, 2.877; P < 0.001) groups.

CONCLUSION

In this study, the BI-RADS categories of preoperative mammography and ultrasonography of patients with invasive breast cancer were associated with prognosis and could be an important factor in making treatment decisions.

摘要

目的

乳腺影像报告和数据系统(BI-RADS)是一种系统且标准化的乳腺放射学检查结果分类方案。然而,既往研究显示,不同乳腺癌的临床特征对应不同的BI-RADS分类。我们分析了BI-RADS分类与乳腺癌临床病理特征及预后之间的关联。

方法

利用韩国乳腺癌协会登记系统的大规模数据,对术前乳腺钼靶或超声检查中被归类为BI-RADS 3、4或5类的44184例浸润性乳腺癌患者进行回顾性分析。比较乳腺钼靶组和超声检查组中,根据BI-RADS分类(BI-RADS 3-4类和BI-RADS 5类)划分的临床病理因素及预后差异。两组临床病理因素的比较采用逻辑回归分析,而预后则基于使用Kaplan-Meier法和Cox比例风险模型得出的乳腺癌特异性生存率。

结果

在乳腺钼靶组中,与BI-RADS相关的因素有T分期、N分期、可触及性、组织学分级和淋巴管浸润;在超声检查组中,与BI-RADS相关的因素有N分期、可触及性、组织学分级和淋巴管浸润。在生存分析中,乳腺钼靶组(风险比[HR],3.366;P<0.001)和超声检查组(HR,2.877;P<0.001)中,不同BI-RADS分类组的乳腺癌特异性生存率均存在显著差异。

结论

在本研究中,浸润性乳腺癌患者术前乳腺钼靶和超声检查的BI-RADS分类与预后相关,且可能是制定治疗决策的重要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b92/8424435/2d04f561fe62/astr-101-131-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b92/8424435/42816232c298/astr-101-131-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b92/8424435/2d04f561fe62/astr-101-131-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b92/8424435/42816232c298/astr-101-131-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b92/8424435/2d04f561fe62/astr-101-131-g002.jpg

相似文献

1
Comparison of clinicopathological characteristics and prognosis in breast cancer patients with different Breast Imaging Reporting and Data System categories.不同乳腺影像报告和数据系统分类的乳腺癌患者临床病理特征及预后比较
Ann Surg Treat Res. 2021 Sep;101(3):131-139. doi: 10.4174/astr.2021.101.3.131. Epub 2021 Aug 31.
2
3
Estimation of percentage breast tissue density: comparison between digital mammography (2D full field digital mammography) and digital breast tomosynthesis according to different BI-RADS categories.乳腺组织密度百分比的估计:数字乳腺钼靶摄影(二维全视野数字化乳腺钼靶摄影)与数字乳腺断层合成技术在不同 BI-RADS 分类中的比较。
Br J Radiol. 2013 Nov;86(1031):20130255. doi: 10.1259/bjr.20130255. Epub 2013 Sep 12.
4
Mammographic breast density and survival in women with invasive breast cancer.乳腺癌患者的乳腺 X 线摄影密度与生存。
Cancer Causes Control. 2022 Sep;33(9):1207-1213. doi: 10.1007/s10552-022-01590-x. Epub 2022 Jun 13.
5
Breast Density Estimation with Fully Automated Volumetric Method: Comparison to Radiologists' Assessment by BI-RADS Categories.基于全自动容积法的乳腺密度估计:与放射科医生通过BI-RADS分类进行的评估比较。
Acad Radiol. 2016 Jan;23(1):78-83. doi: 10.1016/j.acra.2015.09.012. Epub 2015 Oct 27.
6
BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.BI-RADS 类别 5 评估在诊断性乳房成像中的应用:基于病变描述符的结果分析。
Acad Radiol. 2019 Aug;26(8):1048-1052. doi: 10.1016/j.acra.2018.07.018. Epub 2018 Sep 5.
7
Breast ultrasonographic and histopathological characteristics without any mammographic abnormalities.乳腺超声及组织病理学特征均无任何异常表现,乳腺 X 线检查也未见异常。
Jpn J Clin Oncol. 2012 Mar;42(3):168-74. doi: 10.1093/jjco/hyr197. Epub 2012 Jan 4.
8
Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk.临床乳腺钼靶密度的纵向测量以改善乳腺癌风险评估。
J Natl Cancer Inst. 2007 Mar 7;99(5):386-95. doi: 10.1093/jnci/djk066.
9
Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers: A Case-Control Study.自动化和临床乳腺成像报告和数据系统密度测量预测筛查和间期癌症的风险:病例对照研究。
Ann Intern Med. 2018 Jun 5;168(11):757-765. doi: 10.7326/M17-3008. Epub 2018 May 1.
10
Positive predictive value of BI-RADS MR imaging.BI-RADS MR 成像的阳性预测值。
Radiology. 2012 Jul;264(1):51-8. doi: 10.1148/radiol.12110619. Epub 2012 May 15.

引用本文的文献

1
Stratifying Breast Lesion Risk Using BI-RADS: A Correlative Study of Imaging and Histopathology.使用乳腺影像报告和数据系统(BI-RADS)对乳腺病变风险进行分层:影像学与组织病理学的相关性研究
Medicina (Kaunas). 2025 Jul 10;61(7):1245. doi: 10.3390/medicina61071245.
2
Determining whether the diagnostic value of B-ultrasound combined with contrast-enhanced ultrasound and shear wave elastography in breast mass-like and non-mass-like lesions differs: a diagnostic test.确定B超联合超声造影及剪切波弹性成像在乳腺肿块样和非肿块样病变中的诊断价值是否存在差异:一项诊断试验。
Gland Surg. 2023 Feb 28;12(2):282-296. doi: 10.21037/gs-23-51. Epub 2023 Feb 24.
3

本文引用的文献

1
Breast Cancer Statistics in Korea in 2017: Data from a Breast Cancer Registry.2017年韩国乳腺癌统计数据:来自乳腺癌登记处的数据
J Breast Cancer. 2020 Apr;23(2):115-128. doi: 10.4048/jbc.2020.23.e24.
2
Value of digital mammography in predicting lymphovascular invasion of breast cancer.数字乳腺 X 线摄影在预测乳腺癌淋巴管血管侵犯中的价值。
BMC Cancer. 2020 Apr 3;20(1):274. doi: 10.1186/s12885-020-6712-z.
3
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017.韩国癌症统计数据:2017 年发病率、死亡率、生存率和患病率。
Accuracy and Utility of Preoperative Ultrasound-Guided Axillary Lymph Node Biopsy for Invasive Breast Cancer: A Systematic Review and Meta-Analysis.
术前超声引导下腋窝淋巴结活检在浸润性乳腺癌中的准确性和实用性:系统评价和荟萃分析。
Comput Intell Neurosci. 2022 Sep 27;2022:3307627. doi: 10.1155/2022/3307627. eCollection 2022.
4
Subsequent pregnancy and long-term safety after breast cancer: a retrospective analysis of Korean health insurance data.乳腺癌后的后续妊娠及长期安全性:韩国健康保险数据的回顾性分析
Ann Surg Treat Res. 2022 Feb;102(2):73-82. doi: 10.4174/astr.2022.102.2.73. Epub 2022 Feb 4.
Cancer Res Treat. 2020 Apr;52(2):335-350. doi: 10.4143/crt.2020.206. Epub 2020 Mar 16.
4
Tumor Proliferation and Invasiveness Derived From Ultrasound Appearances of Invasive Breast Cancers: Moving Beyond the Routine Differential Diagnosis.浸润性乳腺癌超声表现所衍生的肿瘤增殖与侵袭性:超越常规鉴别诊断
J Ultrasound Med. 2020 Aug;39(8):1589-1599. doi: 10.1002/jum.15250. Epub 2020 Mar 2.
5
Clinical and epidemiologic factors associated with breast cancer and its subtypes among Northeast Chinese women.与中国东北地区女性乳腺癌及其亚型相关的临床和流行病学因素。
Cancer Med. 2019 Dec;8(17):7431-7445. doi: 10.1002/cam4.2589. Epub 2019 Oct 23.
6
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.估算 2018 年全球癌症发病率和死亡率:GLOBOCAN 来源和方法。
Int J Cancer. 2019 Apr 15;144(8):1941-1953. doi: 10.1002/ijc.31937. Epub 2018 Dec 6.
7
Predicting the molecular subtype of breast cancer based on mammography and ultrasound findings.基于乳房X光检查和超声检查结果预测乳腺癌的分子亚型。
Indian J Radiol Imaging. 2018 Jul-Sep;28(3):354-361. doi: 10.4103/ijri.IJRI_78_18.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
Differences between palpable and nonpalpable tumors in early-stage, hormone receptor-positive breast cancer.早期激素受体阳性乳腺癌中可触及与不可触及肿瘤的差异。
Am J Surg. 2018 Aug;216(2):326-330. doi: 10.1016/j.amjsurg.2018.02.020. Epub 2018 Feb 17.
10
Correlation of the ultrasound imaging of breast cancer and the expression of molecular biological indexes.乳腺癌超声成像与分子生物学指标表达的相关性
Pak J Pharm Sci. 2017 Jul;30(4(Suppl.)):1425-1430.